Notes from the analytical desk
Documented analytical context — peptide COAs, HPLC verification, endotoxin testing, compound comparisons. Long-form research notes from the Lumin Research desk.
How to vet a research-peptide supplier in 2026
A documentation-first framework for evaluating research-peptide suppliers — the certificates, lab credentials, and lot-level records that separate verifiable vendors from the rest, and the red flags that should end the conversation.
Ipamorelin research overview — sequence, class, and analytical context
A documented overview of Ipamorelin (Pentapeptide-22) for research use — its sequence and class as a growth-hormone secretagogue, the receptor pathway it acts on in research models, stability considerations, and the analytical specifications a credible lot should meet.
NAD+ research overview — coenzyme chemistry and analytical context
A documented overview of NAD+ (nicotinamide adenine dinucleotide) for research use — its coenzyme chemistry, the redox and signaling pathways it participates in, stability considerations, and the analytical specifications a credible lot should meet.
How to read a peptide certificate of analysis
A breakdown of every field on a typical research-peptide COA — what HPLC purity actually measures, how endotoxin limits are interpreted, and which red flags should send you back to the vendor.
BPC-157 research overview — the analytical context
A documented overview of BPC-157 (Body Protection Compound) — sequence, stability profile, common analytical specifications, and the research literature most frequently cited in vendor materials.
BPC-157 vs TB-500 — a research-context comparison
A side-by-side analytical comparison of BPC-157 and TB-500 — sequence length, stability, common purity specifications, and the distinct research literatures each compound occupies.